Table 2 First line treatment modality received.

From: A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study

Treatment modality

n (%)

Overall (n = 178)

Singapore (n = 64)

Korea (n = 114)

Supportive care only

2 (1.1)

2 (3.1)

0 (0)

Radiation only

8 (4.5)

8 (12.5)

0 (0)

Concurrent chemoradiation

60 (33.7)

0 (0)

60 (52.6)

Chemotherapy

108 (60.7)

54 (84.4)

54 (47.4)

• Anthracycline-based

20 (11.2)

15 (23.4)

5 (4.4)

• Gemcitabine-based

12 (6.7)

12 (18.8)

0 (0)

• SMILE

36 (20.2)

4 (6.3)

32 (28.1)

• Others

40 (22.5)

23 (35.9)

17 (14.9)

Back to article page